Ebola virus disease requires intensive supportive care across multiple symptom domains. Severe pain is a clinically significant component of the disease course and demands structured pharmacological management — for adult patients and for paediatric patients above 6 months of age.
The protocol specifies an analgesic agent for severe pain, with separate dosing guidance for adults and for children over 6 months. Structured schedules define how frequently the agent may be given and the maximum daily dose for each population. Full selection criteria, the complete dosing schedule, and route-of-administration details are available in the structured protocol below.